Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Balance Sheets

v3.3.1.900
Condensed Consolidated Interim Balance Sheets - USD ($)
Jun. 30, 2015
Dec. 31, 2014
Current    
Cash and cash equivalents $ 9,078,216 $ 209,933
Prepaid expenses and other receivables (Note 4) 164,353 81,130
Due from related parties (Note 8) 42,151 44,986
Loan receivable (Note 5) 150,000 0
Total Current Assets 9,434,720 336,049
Equipment (Note 6) 114,544 77,922
Total Assets 9,549,264 413,971
Current    
Accounts payable (Note 8) 197,082 308,947
Accrued liabilities 33,270 155,463
Warrant Derivative Liability (Note 11) 12,021,717 0
Total Liabilities 12,252,069 464,410
Shareholders' Deficiency    
Special Voting Preferred Stock, par value $0.001; Authorized - 1; Issued and outstanding - 1 (December 31, 2014 - Nil) 0 0
Common Shares, par value $0.001; Authorized - 150,000,000 (December 31, 2014 - 200,000,000); Issued and outstanding - 22,408,313 and 50,000,000 Exchangeable Shares (December 31, 2014 - nil and 49,737,096 Exchangeable Shares) (Note 9) 72,408 49,737
Additional paid in capital 11,372,384 4,936,456
Deficit (14,189,746) (5,053,982)
Accumulated other comprehensive income 42,149 17,350
Total Shareholders' Deficiency (2,702,805) (50,439)
Total Liabilities and Shareholders' Deficiency $ 9,549,264 $ 413,971